Calciphylaxis in primary hyperparathyroidism: a case report and brief review.

Calciphylaxis remains a poorly understood condition with limited diagnostic and therapeutic guidance. Prior research has shown that it primarily affects patients with chronic kidney disease or those undergoing dialysis. However, cases outside these populations are rare and poorly documented. This gap motivated the exploration of calciphylaxis in the context of primary hyperparathyroidism. No prior work had resolved the mechanisms linking hyperparathyroidism to calciphylaxis. The condition's rarity and non-specific symptoms make early diagnosis challenging. Established knowledge includes its association with calcium and vitamin D metabolism. This paper's contribution lies in presenting a case where calciphylaxis occurred in a patient with primary hyperparathyroidism. The absence of renal disease in this case expands the known clinical spectrum.

The aim of this case report is to document a rare instance of calciphylaxis in a patient with primary hyperparathyroidism. The specific problem involves understanding the possible link between parathyroid dysfunction and calciphylaxis. The motivation stems from the lack of prior documentation of such a case. The authors sought to highlight the diagnostic and therapeutic challenges in this context. They aimed to provide a clinical narrative to raise awareness among endocrinologists and surgeons. The case also serves to emphasize the importance of timely intervention in hyperparathyroidism. The patient's presentation with non-healing ulcers and abnormal lab values prompted further investigation. This report contributes to the limited literature on calciphylaxis in non-renal settings.

The study involved a clinical case analysis of a 52-year-old woman with non-healing skin ulcers. Laboratory tests were conducted to assess calcium, phosphorus, and parathyroid hormone levels. A technetium-sestamibi scan was used to identify a parathyroid adenoma. The patient underwent parathyroidectomy to address the hyperparathyroidism. Post-operative wound care included broad-spectrum antibiotics and local treatments. The authors reviewed existing literature to contextualize their findings. They analyzed the patient's medical history and lab results to identify contributing factors. The case was documented in detail to provide a reference for future clinical encounters.

The patient presented with severe hypercalcemia, low phosphorus, and elevated parathyroid hormone levels. Imaging confirmed a left inferior parathyroid adenoma. Parathyroidectomy was performed, and pathology confirmed the diagnosis. Despite wound care and antibiotics, the patient developed sepsis and died. The case highlights the severity of calciphylaxis in non-renal patients. The patient's corrected calcium level was 14.8 mg/dL, far above normal ranges. Parathyroid hormone levels were 893.3 pg/mL, indicating significant dysfunction. The case underscores the need for early recognition and treatment of calciphylaxis.

The authors propose that calciphylaxis can occur in patients with primary hyperparathyroidism. This case expands the known clinical associations of calciphylaxis beyond renal disease. The patient's outcome emphasizes the importance of prompt diagnosis and treatment. The study does not establish causation but suggests a possible link between hyperparathyroidism and calciphylaxis. The findings suggest that clinicians should consider calciphylaxis in patients with unexplained skin ulcers. The authors do not claim that parathyroidectomy prevents calciphylaxis but note its role in managing hyperparathyroidism. The case illustrates the challenges in managing calciphylaxis despite surgical intervention. These conclusions are based on the patient's clinical course and the absence of prior documentation.